SATIVOL Trademark

Trademark Overview


On Wednesday, April 22, 2015, a trademark application was filed for SATIVOL with the United States Patent and Trademark Office. The USPTO has given the SATIVOL trademark a serial number of 86606877. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, June 28, 2017. This trademark is owned by MMJ Bioscience Inc.. The SATIVOL trademark is filed in the Natural Agricultural Products category with the following description:

cannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; pharmaceuticals, pharmaceutical preparations, and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumat...
sativol

General Information


Serial Number86606877
Word MarkSATIVOL
Filing DateWednesday, April 22, 2015
Status601 - ABANDONED - EXPRESS
Status DateWednesday, June 28, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicescannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; pharmaceuticals, pharmaceutical preparations, and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; Dietary and nutritional supplements containing cannabidiol (CBD); pharmaceuticals, pharmaceutical preparations, and nutraceuticals containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; nutritional and dietary supplements; food supplements; medicines containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; magnetically encoded cards, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; magnetically encoded identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; consumer products, namely, edible oils; consumer products, namely, non-alcoholic beverages, namely, soft drinks, fruit drinks, vegetable drinks, and juices; consumer products, namely, smokeless vaporizer pipes and pens; online retail store wholesale services featuring CBD based pharmaceutical and body care products derived from industrial hemp; mail order buying clubs in the field of pharmaceutical products; membership services, namely, the operation and maintenance of an association promoting the interests of retail and wholesale stores in the field of medical marihuana; membership services, namely, providing discounts and processing rebates for the goods and services of others in the medical marijuana industry; retail and wholesale store services featuring CBD based pharmaceutical products derived from industrial hemp; retail and wholesale store services featuring pharmaceuticals containing CBDs; promoting the goods and services of others by issuance of rewards cards related to the purchase of CBD based products; retail and wholesale store reward programs to promote the sale of pharmaceuticals containing CBDs; providing a customer loyalty program which promotes the goods and services of others by offering rewards, bonus points or discount offers; providing consumer information in the field of medical marijuana; providing a website featuring commercial information regarding medical marijuana dispensaries; providing a website featuring information regarding political and business information regarding the medical marijuana and cannabis industries; providing discounts and processing rebates for retail stores and wholesale stores in the medical marijuana field; assembly of pharmaceuticals for others; customized production of pharmaceuticals, pharmaceutical products, nutraceuticals and CBD based products derived from industrial hemp; extraction of CBD derived from industrial hemp; scientific research services in the area of CBD based products derived from industrial hemp; product development services for products containing CBD based products derived from industrial hemp; research and development of products containing CBDs for others for clinical studies; providing a website featuring information regarding scientific and medical research in the field of cannabis and medical marijuana; operation of a web site that provides online social networking; providing a website featuring legal information regarding marijuana, cannabis and CBDs based products derived from industrial hemp

Classification Information


International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateFriday, May 1, 2015
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUNITED GREENERIES HOLDINGS LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type13 - Limited Partnership
AddressVANCOUVER V6C2T5
CA

Party NameMMJ Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver V6C2T5
CA

Trademark Events


Event DateEvent Description
Wednesday, June 28, 2017ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, June 28, 2017ABANDONMENT - EXPRESS MAILED
Tuesday, June 27, 2017TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, May 31, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 31, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, May 31, 2017SUSPENSION LETTER WRITTEN
Thursday, May 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 8, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 12, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 12, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, November 9, 2016INQUIRY TO SUSPENSION E-MAILED
Wednesday, November 9, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, October 18, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, April 1, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 1, 2016LETTER OF SUSPENSION E-MAILED
Friday, April 1, 2016SUSPENSION LETTER WRITTEN
Friday, March 4, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 4, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2016ASSIGNED TO LIE
Friday, February 19, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 19, 2015NON-FINAL ACTION E-MAILED
Wednesday, August 19, 2015NON-FINAL ACTION WRITTEN
Tuesday, August 4, 2015ASSIGNED TO EXAMINER
Wednesday, May 20, 2015ASSIGNED TO EXAMINER
Wednesday, May 20, 2015ASSIGNED TO EXAMINER
Friday, May 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM